phosphatidylcholines has been researched along with rifampin in 7 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (rifampin) | Trials (rifampin) | Recent Studies (post-2010) (rifampin) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 20,468 | 1,499 | 6,552 |
| Protein | Taxonomy | phosphatidylcholines (IC50) | rifampin (IC50) |
|---|---|---|---|
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 2.949 | |
| Caspase-1 | Homo sapiens (human) | 8.319 | |
| Alpha-synuclein | Homo sapiens (human) | 7.1 | |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | Mycobacterium tuberculosis H37Rv | 0.03 | |
| DNA-directed RNA polymerase subunit beta | Mycobacterium tuberculosis H37Rv | 0.01 | |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 1.5 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 1.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davydov, VIu; Kisel', MA; Kulik, LN | 1 |
| Deol, P; Khuller, GK | 1 |
| Chung, H; Jeong, SY; Kim, TW; Kwon, IC; Kwon, M | 1 |
| Gürsoy, A; Kut, E; Ozkirimli, S | 1 |
| Chan, HK; Changsan, N; Separovic, F; Srichana, T | 1 |
| Caddeo, C; De Logu, A; Fadda, AM; Lai, F; Manca, ML; Sinico, C; Zaru, M | 1 |
| Patil-Gadhe, A; Pokharkar, V | 1 |
7 other study(ies) available for phosphatidylcholines and rifampin
| Article | Year |
|---|---|
[Entrapment of antibiotics in liposomes containing phosphatidylethanol].
Topics: Anti-Bacterial Agents; Doxorubicin; Doxycycline; Drug Carriers; Glycerophospholipids; Liposomes; Molecular Structure; Phosphatidic Acids; Phosphatidylcholines; Rifampin | 1996 |
Lung specific stealth liposomes: stability, biodistribution and toxicity of liposomal antitubercular drugs in mice.
Topics: Alanine Transaminase; Alkaline Phosphatase; Amylopectin; Animals; Antitubercular Agents; Bilirubin; Cholesterol; Drug Delivery Systems; Isoniazid; Liposomes; Liver; Lung; Macrophages; Mice; Phosphatidylcholines; Rifampin; Transaminases; Tuberculosis | 1997 |
Oil components modulate physical characteristics and function of the natural oil emulsions as drug or gene delivery system.
Topics: Animals; Antibiotics, Antitubercular; Chemical Phenomena; Chemistry, Physical; Chlorocebus aethiops; COS Cells; Cyclooxygenase Inhibitors; Diclofenac; DNA; Drug Delivery Systems; Emulsions; Escherichia coli; Oils; Particle Size; Phosphatidylcholines; Plasmids; Rifampin; Surface Tension; Transfection; Viscosity | 2001 |
Co-encapsulation of isoniazid and rifampicin in liposomes and characterization of liposomes by derivative spectroscopy.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antibiotics, Antitubercular; Chemistry, Pharmaceutical; Cholesterol; Delayed-Action Preparations; Drug Combinations; Isoniazid; Liposomes; Phosphatidylcholines; Rifampin; Solubility; Spectrophotometry, Ultraviolet | 2004 |
Physicochemical characterization and stability of rifampicin liposome dry powder formulations for inhalation.
Topics: Administration, Inhalation; Aerosols; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Cholesterol; Cryoprotective Agents; Drug Compounding; Drug Stability; Freeze Drying; Liposomes; Mannitol; Particle Size; Phosphatidylcholines; Powders; Rifampin; Technology, Pharmaceutical; Temperature; Time Factors | 2009 |
Rifampicin-loaded liposomes for the passive targeting to alveolar macrophages: in vitro and in vivo evaluation.
Topics: Animals; Antibiotics, Antitubercular; Cell Line; Cholesterol; Humans; Liposomes; Macrophages, Alveolar; Male; Mice; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Phosphatidylcholines; Rats; Rats, Wistar; Rifampin | 2009 |
Single step spray drying method to develop proliposomes for inhalation: a systematic study based on quality by design approach.
Topics: Administration, Inhalation; Amines; Animals; Antibiotics, Antitubercular; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Liberation; Female; Glycine max; Half-Life; Liposomes; Lung; Male; Particle Size; Phosphatidylcholines; Rats; Regression Analysis; Rifampin; Tissue Distribution | 2014 |